Zhdanava, Maryia
Kachroo, Sumesh
Boonmak, Porpong
Burbage, Sabree
Shah, Aditi
Lefebvre, Patrick
Kerner, Caroline
Pilon, Dominic
Funding for this research was provided by:
Johnson and Johnson Innovative Medicine, LLC
Article History
Received: 30 May 2024
Accepted: 2 August 2024
First Online: 20 August 2024
Declarations
:
: Sumesh Kachroo, Sabree Burbage and Caroline Kerner are employees of Janssen Scientific Affairs, LLC, a Johnson & Johnson company, and own stock/stock options. Maryia Zhdanava, Porpong Boonmak, Aditi Shah, Patrick Lefebvre and Dominic Pilon are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Janssen Scientific Affairs, LLC, a Johnson & Johnson company, which funded the development and conduct of this study and manuscript.
: Data were de-identified and comply with the patient requirements of the Health Insurance Portability and Accountability Act (HIPAA) of 1996; therefore, no review by an institutional review board was required per Title 45 of CFR, Part 46.101(b)(4) ().